Several international heart associations recommend patients already using ACE inhibitors/ARBs and are infected with COVID-19 to continue using their medication (ACEI/ARB Use in COVID-19 Patients With Hypertension; Czarska-Thorley, 2020). This evidence concerns the gene ACE and COVID-19.